Log in or Sign up for Free to view tailored content for your specialty!
Infection News
'Checklist' may help distinguish overlapping features of COVID-19, giant cell arteritis
Giant cell arteritis and COVID-19 both feature headache, fever, elevated C-reactive protein and cough as symptoms, whereas jaw claudication, visual loss and platelet and lymphocyte counts may be more discriminatory, according to findings.
COVID therapies needed beyond vaccine: Role of monoclonal antibodies, convalescent plasma?
November 2020 was a grim time for COVID-19 in the United States, marking the beginning of a brand-new wave of infections fueled by holiday get-togethers that triggered an explosion of cases.
Log in or Sign up for Free to view tailored content for your specialty!
IV immunoglobulin plus methylprednisolone linked to better fever course in MIS-C
Treatment with IV immunoglobulin plus methylprednisolone resulted in a more favorable fever course — and fewer complications — in children with COVID-19-related multisystem inflammatory syndrome than IV immunoglobulins alone.
Obesity drives risk for COVID-19 among Latino patients with rheumatic disease
Latino patients with rheumatic disease have a high rate of COVID-19, with obesity identified as a key risk factor for infection, which, in turn, was linked to increased risk for rheumatic disease flare, according to data.
Navigating COVID-19 vaccine hesitancy: What are you telling your patients?
With two COVID-19 vaccines from Moderna and Pfizer-BioNTech now in circulation and individuals nationwide receiving their initial doses, patients and providers have questions — a lot of questions.
TNF inhibitors, methotrexate may not worsen outcomes in COVID-19
Patients being treated with tumor necrosis factor inhibitors or methotrexate who acquired COVID-19 did not experience elevated hospitalization or mortality rates, according to a study.
Patients with inflammatory rheumatic disease more likely to be hospitalized with COVID-19
Patients with inflammatory rheumatic disease exhibited a higher incidence of COVID-19 hospitalization than the general population, and those with rheumatoid arthritis are at a greater risk for severe outcomes, according to data.
COVID-19 and the Rheumatologist: The Good, the Bad and the Ugly
We end the year with Leonard Calabrese, DO, giving us a summary of what we’ve learned about COVID-19 from the perspective of a rheumatologist.
Risks for severe COVID-19 outcomes in patients with rheumatic disease 'remain substantial'
Although the risk for severe COVID-19 outcomes in patients with rheumatic and musculoskeletal disease has lowered, it is nonetheless still significant, according to data published in The Lancet Rheumatology.
Steroids, not DMARDs, increase risk for COVID-19 infection in inflammatory arthritis
Glucocorticoids, even at a low dose, may increase the risk for COVID-19, while immunomodulatory treatments appear safe for patients with inflammatory arthritis, according to data published in Arthritis Research & Therapy.
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read